fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 7 Oct 2026

GLENMARK, full dossier

Glenmark Therapeutics Inc., USA announced the launch of Adapalene Gel USP, 0.1 per cent (OTC) in new pump packs in the US.

3 publishers have reported this development. Each act of reporting is below, cited.

The record

Glenmark Therapeutics Inc., USA announced the launch of Adapalene Gel USP, 0.1 per cent (OTC) in new pump packs in the US.

expresspharma.in6 Oct 2026

Glenmark Pharmaceuticals US-arm has launched the over-the-counter acne drug Adapalene in new pump packs.

indiatimes.com6 Oct 2026

Glenmark Therapeutics, USA, has launched Adapalene Gel USP, 0.1%, in new pump packs in the American over-the-counter market.

financialexpress.com6 Oct 2026

Glenmark Pharmaceuticals

₹2,295.00

▼ -1.54%

Close (EOD), as of 5 Oct 2026 · source

Glenmark Pharmaceuticals: results, dividends, orders, the full cited record →

More on Glenmark Pharmaceuticals

Indian pharmaceutical industry leaders stated that companies must invest in research and development and shift from generics to an innovation-led industry.

7 Oct 2026 · 1 publisher

Glenmark Pharmaceuticals expects innovative drugs to contribute a higher share of revenue as it shifts focus beyond generics, CMD Glenn Saldanha said.

6 Oct 2026 · 1 publisher

Symbiotec Pharmalab announced the receipt of an establishment inspection report (EIR) from the U.S. Food and Drug Administration (US FDA) for its manufacturing facility in Pithampur (SEZ), Madhya Pradesh, with a voluntary action indicated (VAI) status.

30 Sep 2026 · 7 publishers

Two more persons were arrested in Uttarakhand in connection with the spurious Telma-AM tablets investigation.

28 Sep 2026 · 1 publisher

Dr Reddys Laboratories Ltd is quoting at Rs 1213, up 0.17% on the day as on 12:44 IST on the NSE.

24 Sep 2026 · 2 publishers

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.